Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PICIBANIL (OK-432) pleurodesis for pulmonary fistula
jRCTs031180293Recruiting
- Sponsor
- Nippon Zoki Pharmaceutical
- Start
- Aug 2018
- Modality
- Therapeutic Vaccines → Vaccines & Immunotherapeutics, Cell Therapies, Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of streptococcus pyogenes preparation in pneumothorax, Pulmonary fistula and air-leak syndrome, sponsored by Nippon Zoki Pharmaceutical. Started Aug 2018; status: recruiting.
02
Drugs
streptococcus pyogenes preparation
03
Conditions
pneumothoraxPulmonary fistulaair-leak syndrome
Beyond the preview
Go deeper on jRCTs031180293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180293.